These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11788417

  • 21. [A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris].
    Shavarov AA, Kiiakbaev GK, Kobalava ZhD.
    Ter Arkh; 2013; 85(4):77-83. PubMed ID: 23808298
    [Abstract] [Full Text] [Related]

  • 22. Assessment of the pharmacological effects of inotropic drugs on left ventricular pressure and contractility: an evaluation of the QA interval as an indirect indicator of cardiac inotropism.
    Norton K, Iacono G, Vezina M.
    J Pharmacol Toxicol Methods; 2009; 60(2):193-7. PubMed ID: 19523528
    [Abstract] [Full Text] [Related]

  • 23. Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs.
    Colin P, Ghaleh B, Monnet X, Hittinger L, Berdeaux A.
    J Pharmacol Exp Ther; 2004 Jan; 308(1):236-40. PubMed ID: 14569053
    [Abstract] [Full Text] [Related]

  • 24. Heart Rate Control during Experimental Sepsis in Mice: Comparison of Ivabradine and β-Blockers.
    Bedet A, Voiriot G, Ternacle J, Marcos E, Adnot S, Derumeaux G, Mekontso Dessap A.
    Anesthesiology; 2020 Feb; 132(2):321-329. PubMed ID: 31939847
    [Abstract] [Full Text] [Related]

  • 25. Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol.
    Stoleru L, Wijns W, van Eyll C, Bouvy T, Van Nueten L, Pouleur H.
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):183-90. PubMed ID: 7692155
    [Abstract] [Full Text] [Related]

  • 26. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
    Maczewski M, Mackiewicz U.
    Cardiovasc Res; 2008 Jul 01; 79(1):42-51. PubMed ID: 18310678
    [Abstract] [Full Text] [Related]

  • 27. Preclinical results with I(f) current inhibition by ivabradine.
    Berdeaux A.
    Drugs; 2007 Jul 01; 67 Suppl 2():25-33. PubMed ID: 17999561
    [Abstract] [Full Text] [Related]

  • 28. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C.
    Circulation; 2004 Apr 06; 109(13):1674-9. PubMed ID: 14981003
    [Abstract] [Full Text] [Related]

  • 29. Beta adrenergic blockade with propranolol and atenolol in the exercising dog: evidence for beta 2 adrenoceptors in the sinoatrial node.
    Friedman DB, Musch TI, Williams RS, Ordway GA.
    Cardiovasc Res; 1987 Feb 06; 21(2):124-9. PubMed ID: 2822246
    [Abstract] [Full Text] [Related]

  • 30. Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures.
    Wang J, Khoury DS, Thohan V, Torre-Amione G, Nagueh SF.
    Circulation; 2007 Mar 20; 115(11):1376-83. PubMed ID: 17339549
    [Abstract] [Full Text] [Related]

  • 31. Mechanisms of benefit in the ischemic myocardium due to heart rate reduction.
    Guth BD, Indolfi C, Heusch G, Seitelberger R, Ross J.
    Basic Res Cardiol; 1990 Mar 20; 85 Suppl 1():157-66. PubMed ID: 1965395
    [Abstract] [Full Text] [Related]

  • 32. Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy.
    Christensen LP, Zhang RL, Zheng W, Campanelli JJ, Dedkov EI, Weiss RM, Tomanek RJ.
    Am J Physiol Heart Circ Physiol; 2009 Jul 20; 297(1):H322-30. PubMed ID: 19411283
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Myocardial flow and function after regional beta-blockade in exercising dogs.
    Mass H, Gwirtz PA.
    Med Sci Sports Exerc; 1987 Oct 20; 19(5):443-50. PubMed ID: 2891014
    [Abstract] [Full Text] [Related]

  • 35. Novel If current inhibitor ivabradine: safety considerations.
    Savelieva I, Camm AJ.
    Adv Cardiol; 2006 Oct 20; 43():79-96. PubMed ID: 16936474
    [Abstract] [Full Text] [Related]

  • 36. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D, Camm JA.
    Drugs; 2004 Oct 20; 64(16):1757-65. PubMed ID: 15301560
    [Abstract] [Full Text] [Related]

  • 37. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation.
    Nemoto S, Hamawaki M, De Freitas G, Carabello BA.
    J Am Coll Cardiol; 2002 Jul 03; 40(1):149-54. PubMed ID: 12103269
    [Abstract] [Full Text] [Related]

  • 38. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
    Gerbaud E, Montaudon M, Chasseriaud W, Gilbert S, Cochet H, Pucheu Y, Horovitz A, Bonnet J, Douard H, Coste P.
    Arch Cardiovasc Dis; 2014 Jan 03; 107(1):33-41. PubMed ID: 24440004
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.